Gastric endoscopic submucosal dissection as a treatment for early neoplasia and for accurate staging of early cancers in a United Kingdom Caucasian population

Table 6 Secondary outcome in the cohort‘ indefinite for curative resection or non- curative resection

Variable	Indefinite, n = 10	CR, n = 5
Number of patients under endoscopic follow-up, n (%)	9 (90)	5 (100)
Median follow-up, mo	2	3
Mean follow-up, mo	5.1	8.5
Range, mo	0-19	0-22
Length of time since ESD, mean ± SD, mo	13.3 ± 11.3	12.2 ± 11.1
Length of time since ESD, range, mo	2 - 38	0 - 26
Number of patients with metachronous or synchronous disease post ESD, n	2	0

ESD: Endoscopic submucosal dissection; CR: Curative resection.